Evidence map›Paper›PMID 23761484›Full record

Trial reportThe American journal of clinical nutrition2013

Modulation of DNA methylation states and infant immune system by dietary supplementation with ω-3 PUFA during pregnancy in an intervention study.

Ho-Sun Lee, Albino Barraza-Villarreal, Hector Hernandez-Vargas, Peter D Sly, Carine Biessy, Usha Ramakrishnan, Isabelle Romieu, Zdenko Herceg

Open access · greenAbstract readRandomized Controlled Trial
In one paragraph

Trial report in The American journal of clinical nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed, 2 pooled it
10.4field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 2 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Omega-3 fatty acid addition during pregnancy.The Cochrane database of systematic reviews · 2018
    Pooled it
  2. Pooled it
  3. Trial
  4. Maternal fatty acid concentrations and newborn DNA methylation.The American journal of clinical nutrition · 2020
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Ho-Sun LeeInternational Agency for Research on Cancer, Lyon, France.
Albino Barraza-Villarreal
Hector Hernandez-Vargas
Peter D Sly
Carine Biessy
Usha Ramakrishnan
Isabelle Romieu
Zdenko Herceg
Centre international de recherche sur le cancer · FR

Funding

Effect of Prenatal DHA Supplements on Infant DevelopmentR01HD043099 · NICHD · EMORY UNIVERSITY · PI RAMAKRISHNAN, USHA · 2004 to 2012
$4.1M
Omega fatty acid supplementation and allergic diseases in childrenR01HD058818 · NICHD · MEXICO NATIONAL INSTITUTE OF PUBLIC HLTH · PI ROMIEU, ISABELLE · 2009 to 2012
$768k
NICHD NIH HHS R01 HD043099NICHD NIH HHS R01HD058818
6 · The paper itself

Abstract

backgroundEarly-life exposures to tobacco smoke and some dietary factors have been identified to induce epigenetic changes in genes involved in allergy and asthma development. Omega-3 (n-3) polyunsaturated fatty acid (PUFA) intake during pregnancy could modulate key cytokines and T helper (Th) cell maturation; however, little is known about the mechanism by which ω-3 PUFA could have a beneficial effect in preventing inflammatory disorders.

objectiveWe sought to test whether prenatal dietary supplementation with ω-3 PUFA during pregnancy may modulate epigenetic states in the infant immune system.

designThis study was based on a randomized intervention trial conducted in Mexican pregnant women supplemented daily with 400 mg docosahexaenoic acid (DHA) or a placebo from 18 to 22 wk of gestation to parturition. We applied quantitative profiling of DNA methylation states in Th1, Th2, Th17, and regulatory T-relevant genes as well as LINE1 repetitive elements of cord blood mononuclear cells (n = 261).

resultsNo significant difference in promoter methylation levels was shown between ω-3 PUFA-supplemented and control groups for the genes analyzed; however, ω-3 PUFA supplementation was associated with changes in methylation levels in LINE1 repetitive elements (P = 0.03) in infants of mothers who smoked during pregnancy. Furthermore, an association between the promoter methylation levels of IFNγ and IL13 was modulated by ω-3 PUFA supplementation (P = 0.06).

conclusionsOur results indicate that maternal supplementation with ω-3 PUFA during pregnancy may modulate global methylation levels and the Th1/Th2 balance in infants. Therefore, the epigenetic mechanisms could provide attractive targets for prenatal modulation and prevention of inflammatory disorders and potentially other related diseases in childhood and adulthood.

Indexed as

Dietary SupplementsPrenatal Nutritional Physiological PhenomenaAdolescentAdultDNA MethylationDouble-Blind MethodEpigenesis, GeneticFatty Acids, Omega-3FemaleHumansImmune SystemInfantInterferon-gammaInterleukin-13Linear ModelsMexicoFatty Acids, Omega-3Interferon-gammaInterleukin-13

Identifiers

PMID23761484
PMCPMC3712555
OpenAlexW2113880105

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.